Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 35810754

Zanubrutinib versus bendamustine and rituximab in untreated chronic lymphocytic leukaemia and small lymphocytic lymphoma (SEQUOIA): a randomised, controlled, phase 3 trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2022 Aug
First author
Tam CS

This record carries publication-notice metadata. Review the notices below before relying on it.

Publication notices

absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2022 Aug;23(8):965-967. doi: 10.1016/S1470-2045(22)00379-5.
    note
    Source null
    related pmid
    35810752
    relationship
    Comment in
  2. citation
    Lancet Oncol. 2023 Mar;24(3):e106. doi: 10.1016/S1470-2045(23)00073-6.
    note
    Source null
    related pmid
    36858727
    relationship
    Erratum in

Authors and identifiers

  1. name
    Tam CS
    type
    Author
  2. name
    Brown JR
    type
    Author
  3. name
    Kahl BS
    type
    Author
  4. name
    Ghia P
    type
    Author
  5. name
    Giannopoulos K
    type
    Author
  6. name
    Jurczak W
    type
    Author
  7. name
    Šimkovič M
    type
    Author
  8. name
    Shadman M
    type
    Author
  9. name
    Österborg A
    type
    Author
  10. name
    Laurenti L
    type
    Author
  11. name
    Walker P
    type
    Author
  12. name
    Opat S
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Tam CS
    type
    Author
  2. name
    Brown JR
    type
    Author
  3. name
    Kahl BS
    type
    Author
  4. name
    Ghia P
    type
    Author
  5. name
    Giannopoulos K
    type
    Author
  6. name
    Jurczak W
    type
    Author
  7. name
    Šimkovič M
    type
    Author
  8. name
    Shadman M
    type
    Author
  9. name
    Österborg A
    type
    Author
  10. name
    Laurenti L
    type
    Author
  11. name
    Walker P
    type
    Author
  12. name
    Opat S
    type
    Author
bibliography ids
  1. nci-bib-df4e42a6befd2a8efdd1c9fd
book metadata
content sha256
7b6f1ce445758e2fe9a64ea82f9da92624ae3ad03be780194512ec37d5ec1fe5
document type
citation
dois
  1. 10.1016/S1470-2045(22)00293-5
electronic publication date
display
2022 Jul 7
precision
day
year
2022
evidence scope
bibliographic_metadata_only
id
pubmed:35810754
immutable id
pubmed:35810754@7b6f1ce445758e2fe9a64ea82f9da92624ae3ad03be780194512ec37d5ec1fe5
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
8
name
The Lancet. Oncology
nlm unique id
100957246
pages
1031-1043
volume
23
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2022 Aug;23(8):965-967. doi: 10.1016/S1470-2045(22)00379-5.
    note
    Source null
    related pmid
    35810752
    relationship
    Comment in
  2. citation
    Lancet Oncol. 2023 Mar;24(3):e106. doi: 10.1016/S1470-2045(23)00073-6.
    note
    Source null
    related pmid
    36858727
    relationship
    Erratum in
outcomes validated
false
pmid
35810754
provenance
batch id
9d150d55960e0c12aada
provider
NCBI PubMed ESummary
record sha256
723387cc2aecf00e2cbff86ed7a08e62029f0b2c41203950f55e6b3bfbe43878
response sha256
2d4ef1cc8137eef6e7216f66bf8601c3899bc663b8626f412794d39585de6b6b
retrieved at
2026-09-09T23:48:09.820498+00:00
publication date
display
2022 Aug
precision
month
year
2022
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Randomized Controlled Trial
  4. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/35810754/
title
Zanubrutinib versus bendamustine and rituximab in untreated chronic lymphocytic leukaemia and small lymphocytic lymphoma (SEQUOIA): a randomised, controlled, phase 3 trial.

Preserved source evidence · Not medical advice